Objectives To develop recommendations for the management of adult and paediatric lupus
nephritis (LN). Methods The available evidence was systematically reviewed using the …

Objective To update the 2012 EULAR/ERA–EDTA recommendations for the management of
lupus nephritis (LN). Methods Following the EULAR standardised operating procedures, a …

Renovascular disease is an uncommon but important cause of hypertension in children. It is
usually diagnosed after a long delay because blood pressure is infrequently measured in …

Mutations in hepatocyte nuclear factor 1B (HNF1B), which is a transcription factor expressed
in tissues including renal epithelia, associate with abnormal renal development. While …

Objectives IgA vasculitis (IgAV, formerly known as Henoch–Schönlein purpura) is the most
common cause of systemic vasculitis in childhood. To date, there are no internationally …

The aim of this study was to establish the efficacy and safety of rituximab in refractory nephrotic
syndrome (NS). Members of the International Paediatric Nephrology Association were …

Childhood-onset systemic lupus erythematosus (cSLE) is a rare, multisystem and potentially
life-threatening autoimmune disorder with significant associated morbidity. Evidence-based …

Children and adolescents with COVID-19 fare considerably better than adults, with mortality
rates in paediatric patients (age< 18 years) of less than 1% reported in early studies. 1, 2 …

Lupus nephritis (LN) occurs in 50%–60% of patients with childhood-onset systemic lupus
erythematosus (cSLE), leading to significant morbidity. Timely recognition of renal involvement …

Objective Polyarteritis nodosa (PAN) is a rare disease of childhood. The aims of this study
were to describe the clinical features, treatment, and outcome of systemic childhood PAN and …